In another study using highly metastatic melanoma and colon cancer cells, Gal-9 was reported to suppress tumor cell migration and metastasis, both in vivo and in vitro, possibly by blocking the binding of adhesion molecules on tumor cells to their ligands on ECM and vascular ECs [69]. Here, LGALS9 is linked to melanoma.